Atara Biotherapeutics (ATRA) Enterprise Value: 131.06M

Atara Biotherapeutics, Inc. (ATRA)

9.48 +1.02 (+12.06%) USD | NASDAQ | Oct 02, 16:00

9.60 +0.12 (+1.27%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.

Date	Value
October 02, 2026	131.06M
October 01, 2026	121.43M
September 30, 2026	121.81M
September 29, 2026	117.56M
September 28, 2026	120.58M
September 25, 2026	124.74M
September 24, 2026	122.19M
September 23, 2026	122.38M
September 22, 2026	125.87M
September 21, 2026	130.12M
September 18, 2026	133.05M
September 17, 2026	133.24M
September 16, 2026	137.01M
September 15, 2026	130.69M
September 14, 2026	128.89M
September 11, 2026	130.12M
September 10, 2026	134.94M
September 09, 2026	135.12M
September 08, 2026	138.15M
September 04, 2026	133.71M
September 03, 2026	131.54M
September 02, 2026	130.69M
September 01, 2026	126.72M
August 31, 2026	125.59M
August 28, 2026	128.42M

Date	Value
August 27, 2026	128.89M
August 26, 2026	130.12M
August 25, 2026	134.46M
August 24, 2026	130.87M
August 21, 2026	133.14M
August 20, 2026	130.12M
August 19, 2026	132.20M
August 18, 2026	123.89M
August 17, 2026	120.49M
August 14, 2026	117.94M
August 13, 2026	121.90M
August 12, 2026	128.66M
August 11, 2026	125.96M
August 10, 2026	122.85M
August 07, 2026	121.34M
August 06, 2026	119.45M
August 05, 2026	122.19M
August 04, 2026	124.36M
August 03, 2026	122.28M
July 31, 2026	120.68M
July 30, 2026	118.69M
July 29, 2026	117.65M
July 28, 2026	115.29M
July 27, 2026	114.35M
July 24, 2026	116.14M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks